New research indicates that children infected with COVID-19 may face increased cardiovascular disease risks indicated by ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for nasal congestion relief.

Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of pediatric patients aged 6 to 17 years with ADHD.